Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001225208-17-013378)

Filing Details

Accession Number:: 0001225208-17-013378
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2017-08-08 17:02:03
Reporting Period:: 2017-08-04

Filing Date:: 2017-08-08
Accepted Time:: 2017-08-08 17:02:03
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
78003	Pfizer Inc	PFE	Pharmaceutical Preparations (2834)	135315170

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1372915	C Ian Read	Pfizer Inc.-Corp. Secretary 235 East 42Nd St. New York NY 10017	Chairman & Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2017-08-04	28,116	$34.00	636,293	No	4	S	Direct
Common Stock	Disposition	2017-08-04	68,834	$34.00	221,955	No	4	S	Indirect	By Trust

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Indirect	By Trust

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	10,776	Indirect	By Rule 16b-3 Plan

Footnotes

This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 5, 2017.
In accordance with the provisions of his Grantor Retained Annuity Trust (GRAT), 119,973 shares were transferred from the GRAT to the reporting person's direct ownership on March 16, 2017.